SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 24 filers reported holding SPRING BK PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,000 | +200.0% | 2,242 | +348.4% | 0.00% | – |
| Q2 2020 | $1,000 | -75.0% | 500 | -89.6% | 0.00% | – |
| Q1 2020 | $4,000 | +300.0% | 4,792 | +858.4% | 0.00% | – |
| Q4 2019 | $1,000 | -87.5% | 500 | -78.8% | 0.00% | – |
| Q3 2019 | $8,000 | -52.9% | 2,358 | -50.3% | 0.00% | – |
| Q2 2019 | $17,000 | -37.0% | 4,743 | +85.7% | 0.00% | – |
| Q1 2019 | $27,000 | -67.9% | 2,554 | -68.3% | 0.00% | – |
| Q4 2018 | $84,000 | +2.4% | 8,065 | +18.6% | 0.00% | – |
| Q3 2018 | $82,000 | +141.2% | 6,802 | +135.0% | 0.00% | – |
| Q2 2018 | $34,000 | +3.0% | 2,894 | +38.1% | 0.00% | – |
| Q1 2018 | $33,000 | +50.0% | 2,096 | +31.0% | 0.00% | – |
| Q4 2017 | $22,000 | -35.3% | 1,600 | -20.0% | 0.00% | – |
| Q3 2017 | $34,000 | 0.0% | 2,000 | -20.3% | 0.00% | – |
| Q2 2017 | $34,000 | +61.9% | 2,510 | +7.8% | 0.00% | – |
| Q1 2017 | $21,000 | +425.0% | 2,328 | +517.5% | 0.00% | – |
| Q2 2016 | $4,000 | – | 377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 615,384 | $8,332,000 | 1.29% |
| RTW INVESTMENTS, LP | 250,000 | $3,385,000 | 0.71% |
| Monashee Investment Management LLC | 100,000 | $1,354,000 | 0.57% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 275,728 | $3,733,000 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,000 | $2,370,000 | 0.40% |
| TIEDEMANN ADVISORS, LLC | 362,049 | $4,902,000 | 0.36% |
| Morse Asset Management, Inc | 63,700 | $862,000 | 0.28% |
| Private Capital Advisors, Inc. | 56,250 | $762,000 | 0.25% |
| Crestline Management, LP | 98,581 | $1,335,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 112,500 | $1,523,000 | 0.17% |